BOC Sciences Blog

The Research Progress in SHP2 and the Inhibitors

BOC Sciences has directed sincere efforts toward the R&D of small-molecule inhibitors (inhibitors, agonists, and modulators), which greatly free researchers from material outsourcing and selection workload.

mRNA-vaccine

Common Nucleosides as Raw Materials for In Vitro Diagnosis

Messenger RNA (mRNA) was first discovered in the 1960s, but its instability and immunogenicity have severely hindered the development of mRNA therapy. To solve this problem, researchers have contrived several […]

Small Molecule Drugs for Cancer Immunotherapy

Click Chemistry and Its Applications in Medicinal Chemical Synthesis

Click chemistry has developed organic reaction methodologies that are rapid, effective, and specifically selective, and its reaction system is not sensitive to oxygen or water. This article first reviews the […]

FDA Approved ALK Inhibitors for ALK-Positive Non-Small Cell Lung Cancer

FDA Approved ALK Inhibitors for ALK-Positive Non-Small Cell Lung Cancer

Lung cancer is a major type of cancer in the world, with the highest morbidity and mortality among all malignant tumors. ALK-positive non-small cell lung cancer (ALK+ NSCLC) is a […]

Distearyl Phthalic Acid Amides to Accelerate Cosmetics Formulation and Manufacture

Distearyl Phthalic Acid Amides to Accelerate Cosmetics Formulation and Manufacture

Distearyl Phthalic Acid Amide, also known as N, N-Stearyl Phthalic Acid Amide or N, N-Tollow Phthalic Acid Amide, is a biodegradable ingredient contained in many cosmetics and personal care products, […]

bacteria

Some Facts About HER2-Targeted Drugs

Drugs targeting HER2 have shown excellent clinical efficacy over the 20 years, achieving one milestone after another in the field of cancer therapeutics. This article mainly introduces the development history […]

Cancer

Discovery of BLU-945 Brings Hope to EGFR-Positive NSCLC Patients

Mutations in the epidermal growth factor receptor (EGFR) kinase domain are the oncogenic drivers of this adenocarcinoma. Tyrosine kinase inhibitors (TKIs), developed over the last two decades, targeting EGFR mutations, […]

DNA

FDA Approved Oligonucleotide Drugs

Why oligonucleotide drugs? Synthetic oligonucleotides are the key factor in almost all molecular biological methodologies. They are used in PCR, reverse transcription, sequencing, gene editing, synthetic biology, cloning, single nucleotide […]

drug

The Latest and Most Complete Collection of Cancer Drugs

1. Respiratory system 1.1. Lung cancer Drug Name Trade name CAS Target Description Approved Status Gefitinib lressa 184475-35-2 EGFR Gefitinib effectively inhibits all tyrosine phosphorylation sites on EGFR in both […]

Applications of Flavors and Fragrances in the Food Industry

Applications of Flavors and Fragrances in the Food Industry

Flavors and fragrances are pivotal in the food industry, enhancing the sensory attributes of food products and significantly influencing consumer preferences. Fragrances are added in small amounts in the food […]